DLBCL UNCLASSIFIABLE
Clinical trials for DLBCL UNCLASSIFIABLE explained in plain language.
Never miss a new study
Get alerted when new DLBCL UNCLASSIFIABLE trials appear
Sign up with your email to follow new studies for DLBCL UNCLASSIFIABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is for people with B-cell blood cancers like lymphoma and leukemia. It tests a new drug, BGB-16673, that breaks down a protein helping cancer grow. The goal is to find the right dose and see if it is safe and shrinks tumors. About 146 people in China will take part.
Matched conditions: DLBCL UNCLASSIFIABLE
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 26, 2026 10:52 UTC
-
Radioactive drug boosts CAR T-Cell therapy in Tough-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a radioactive drug (131-I apamistamab) given before CAR T-cell therapy for people with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma. The goal is to find a safe dose and see if the combination is tolera…
Matched conditions: DLBCL UNCLASSIFIABLE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:45 UTC